Uniphage

company

About

Uniphage is a biotech company that eliminates bacterial infections by combining the power of bacteriophages with artificial intelligence.

  • 1 - 10

Details

Last Funding Type
Grant
Last Funding Money Raised
$256K
Industries
Agriculture,Artificial Intelligence,Biotechnology
Founded date
Jan 1, 2020
Number Of Employee
1 - 10
Operating Status
Active

Uniphage is a biotech company that eliminates bacterial infections by combining the power of bacteriophages with artificial intelligence. Their first target disease is citrus greening, an incurable and debilitating disease that costs the United States more than $2 billion each year. Uniphage created the first commercially effective models for computationally predicting safe bacterial viruses against target bacterial infections, as well as discovered a variety of targets. This enables them to deliver new antimicrobial, safe, and precise products to market much more quickly.

Funding Rounds

Number of Funding Rounds
Total Funding Amount
1
$256K
Uniphage has raised a total of $256K in funding over 2 rounds. Their latest funding was raised on Apr 11, 2022 from a Grant round.
Announced Date Round Money Raised Number of Investors Lead Investors Post Valuation
Apr 11, 2022 Grant $256K 1 National Science Foundation Detail

Investors

Number of Lead Investors
Number of Investors
1
1
Uniphage is funded by 1 investors. National Science Foundation are the most recent investors.
Investor Name Lead Investor Funding Round
National Science Foundation Yes Grant